CTSG is a prognostic marker involved in immune infiltration and inhibits tumor progression though the MAPK signaling pathway in non-small cell lung cancer
CTSG inhibits NSCLC development by suppressing the MAPK signaling pathway and is also associated with tumor immunity.
Authors
- Qian Chai (ORCID: https://orcid.org/0000-0002-0938-8166)
- Xueyi Feng
- Yanke Zhang (ORCID: https://orcid.org/0000-0003-4788-8708)
- Qian Dai (ORCID: https://orcid.org/0000-0002-9887-0156)
- Lei Zhao (ORCID: https://orcid.org/0000-0002-2065-4162)
- Hongbin Zhu (ORCID: https://orcid.org/0009-0003-1606-2978)
- Xufeng Yao (ORCID: https://orcid.org/0000-0002-4065-8902)
Institutions
- Anhui Medical University (CN)
- Chaohu Hospital of Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Anhui Mental Health Center (CN)
- Fuyang Second People's Hospital (CN)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1007/s00432-024-06051-3
- Citations
- 6
- Primary Topic
- Oral microbiology and periodontitis research
- Type
- article
- Field-Weighted Citation Impact
- 2.40
Funders
- National Natural Science Foundation of China